Treatment with carvedilol was associated with a nonsignificant risk reduction for mortality compared with metoprolol for diabetic and nondiabetic patients, the researchers note.

• 卡维地洛与美托洛尔相比，没有明显降低糖尿病和非糖尿病患者的死亡风险。